This study aimed to assess the molecular basis of the resistance to carbapenems in clinical isolates of Pseudomonas aeruginosa recovered from a tertiary-level health facility in San José, Costa Rica. A total of 198 non-duplicated isolates were evaluated for their susceptibility to β-lactams, aminoglycosides and fluoroquinolones. The production of metallo-β-lactamases (MBLs), the presence of MBL encoding genes (blaIMP, blaVIM and blaGIM-1) and the occurrence of these genes within class 1 integrons were investigated. In addition, an ERIC2 PCR fingerprinting method was used to elucidate the distribution of the detected MBL genes within the strain collection. Of the 198 isolates tested, 125 (63.1 %) were categorized as carbapenem-resistant. The majority (88.8 %) of the carbapemen-resistant isolates also showed resistance to ceftazidime, cefepime, aztreonam, ticarcillin/clavulanic acid, amikacin, gentamicin, tobramycin, ciprofloxacin and gatifloxacin. Among the carbapenem-resistant isolates, 102 (81.6 %) showed MBL activity. Strikingly, both blaIMP and blaVIM genes were simultaneously detected in most (94.1 %) of the 102 MBL producers. Five carbapenem-resistant MBL producers were positive only for blaIMP genes. Almost 70 % of the isolates examined harboured the intI1 gene, accompanied by the sul1 and qacEΔ1 genes in 136 (99 %) and 122 (89 %) isolates, respectively. The majority (94.4 %) of the carbapenem-resistant isolates carried the intI1 gene, in contrast to 26 % of the carbapenem-susceptible isolates. Ninety-three out of 96 (96.9 %) isolates carrying both blaIMP and blaVIM genes also harboured the intI1, sul1 and qacEΔ1 genes. Gene cassettes from carbapenem-susceptible and MBL-negative carbapenem-resistant isolates encoded aminoglycoside-resistance enzymes (aadA2, aadA4 and aadA6) as well as orfD and qacF genes. RAPD analysis distributed 126 of the isolates in 29 clusters. Eighty of the 90 blaIMP+blaVIM+ isolates were sorted into 16 different clusters, suggesting that the blaIMP and blaVIM genes detected were located within a genetic element capable of lateral transfer. Carbapenem-resistant MBL-positive isolates were recovered from almost all hospital wards and were over-represented in samples obtained from the surgical emergency and intensive care therapy units. Remarkably, three carbapenem-resistant isolates, exhibiting MBL activity and carrying both blaIMP and blaVIM genes, were recovered from outpatients. Sequence analysis of both bla genes in various isolates revealed that they correspond to the alleles blaIMP-18 and blaVIM-2. To our knowledge, this is the first report of the combination of two metallo-β-lactamases encoded by the blaIMP-18 and blaVIM-2 genes in P. aeruginosa.
AndradeS. S., JonesR. N., GalesA. C., SaderH. S.2003; Increasing prevalence of antimicrobial resistance among Pseudomonas aeruginosa isolates in Latin American medical centres: 5 year report of the SENTRY Antimicrobial Surveillance Program (1997-2001). J Antimicrob Chemother 52:140–141 [View Article][PubMed]
BorgianniL., PrandiS., SaldenL., SantellaG., HansonN. D., RossoliniG. M., DocquierJ.-D.2011; Genetic context and biochemical characterization of the IMP-18 metallo-β-lactamase identified in a Pseudomonas aeruginosa isolate from the United States. Antimicrob Agents Chemother 55:140–145 [View Article][PubMed]
BreidensteinE. B. M., de la Fuente-NúñezC., HancockR. E. W.2011; Pseudomonas aeruginosa: all roads lead to resistance. Trends Microbiol 19:419–426 [View Article][PubMed]
Castillo-VeraJ., Ribas-AparicioR. M., NicolauC. J., OliverA., Osorio-CarranzaL., Aparicio-OzoresG.2012; Unusual diversity of acquired β-lactamases in multidrug-resistant Pseudomonas aeruginosa isolates in a Mexican hospital. Microb Drug Resist 18:471–478 [View Article][PubMed]
El GarchF., BogaertsP., BebroneC., GalleniM., GlupczynskiY.2011; OXA-198, an acquired carbapenem-hydrolyzing class D β-lactamase from Pseudomonas aeruginosa.. Antimicrob Agents Chemother 55:4828–4833 [View Article][PubMed]
Garza-RamosU., TinocoP., Silva-SanchezJ., Morfin-OteroR., Rodriguez-NoriegaE., Leon-GarnicaG., SaderH. S., JonesR. N.2008; Metallo-β-lactamase IMP-18 is located in a class 1 integron (In96) in a clinical isolate of Pseudomonas aeruginosa from Mexico. Int J Antimicrob Agents 31:78–80 [View Article][PubMed]
HansonN. D., HossainA., BuckL., MolandE. S., ThomsonK. S.2006; First occurrence of a Pseudomonas aeruginosa isolate in the United States producing an IMP metallo-β-lactamase, IMP-18. Antimicrob Agents Chemother 50:2272–2273 [View Article][PubMed]
HocquetD., PlésiatP., DehecqB., MariotteP., TalonD., BertrandX.ONERBA2010; Nationwide investigation of extended-spectrum β-lactamases, metallo-β-lactamases, and extended-spectrum oxacillinases produced by ceftazidime-resistant Pseudomonas aeruginosa strains in France. Antimicrob Agents Chemother 54:3512–3515 [View Article][PubMed]
LeeM. F., PengC. F., HsuH. J., ChenY. H.2008; Molecular characterisation of the metallo-β-lactamase genes in imipenem-resistant Gram-negative bacteria from a university hospital in southern Taiwan. Int J Antimicrob Agents 32:475–480 [View Article][PubMed]
LeeK., KimC. K., HongS. G., ChoiJ., SongS., KohE., YongD., JeongS. H., YumJ. H.& other authors (2010; Characteristics of clinical isolates of Acinetobacter genomospecies 10 carrying two different metallo-β-lactamases. Int J Antimicrob Agents 36:259–263 [View Article][PubMed]
MartinezE., MarquezC., IngoldA., MerlinoJ., DjordjevicS. P., StokesH. W., ChowdhuryP. R.2012; Diverse mobilized class 1 integrons are common in the chromosomes of pathogenic Pseudomonas aeruginosa clinical isolates. Antimicrob Agents Chemother 56:2169–2172 [View Article][PubMed]
MaschmeyerG., BravenyI.2000; Review of the incidence and prognosis of Pseudomonas aeruginosa infections in cancer patients in the 1990s. Eur J Clin Microbiol Infect Dis 19:915–925 [View Article][PubMed]
MasterR. N., ClarkR. B., KarlowskyJ. A., RamirezJ., BordonJ. M.2011; Analysis of resistance, cross-resistance and antimicrobial combinations for Pseudomonas aeruginosa isolates from 1997 to 2009. Int J Antimicrob Agents 38:291–295 [View Article][PubMed]
PallecchiL., RiccioM. L., DocquierJ. D., FontanaR., RossoliniG. M.2001; Molecular heterogeneity of bla(VIM-2)-containing integrons from Pseudomonas aeruginosa plasmids encoding the VIM-2 metallo-β-lactamase. FEMS Microbiol Lett 195:145–150[PubMed]
PoirelL., NaasT., NicolasD., ColletL., BellaisS., CavalloJ. D., NordmannP.2000; Characterization of VIM-2, a carbapenem-hydrolyzing metallo-β-lactamase and its plasmid- and integron-borne gene from a Pseudomonas aeruginosa clinical isolate in France. Antimicrob Agents Chemother 44:891–897 [View Article][PubMed]
PoirelL., LambertT., TürkoglüS., RoncoE., GaillardJ. L., NordmannP.2001; Characterization of Class 1 integrons from Pseudomonas aeruginosa that contain the bla(VIM-2) carbapenem-hydrolyzing β-lactamase gene and of two novel aminoglycoside resistance gene cassettes. Antimicrob Agents Chemother 45:546–552 [View Article][PubMed]
RosserS. J., YoungH. K.1999; Identification and characterization of class 1 integrons in bacteria from an aquatic environment. J Antimicrob Chemother 44:11–18 [View Article][PubMed]
SevillanoE., GallegoL., García-LoboJ. M.2009; First detection of the OXA-40 carbapenemase in P. aeruginosa isolates, located on a plasmid also found in A. baumannii.. Pathol Biol (Paris) 57:493–495 [View Article][PubMed]
SpeijerH., SavelkoulP. H., BontenM. J., StobberinghE. E., TjhieJ. H.1999; Application of different genotyping methods for Pseudomonas aeruginosa in a setting of endemicity in an intensive care unit. J Clin Microbiol 37:3654–3661[PubMed]
TalbotG. H., BradleyJ., EdwardsJ. E.Jr, GilbertD., ScheldM., BartlettJ. G.Antimicrobial Availability Task Force of the Infectious Diseases Society of America2006; Bad bugs need drugs: an update on the development pipeline from the Antimicrobial Availability Task Force of the Infectious Diseases Society of America. Clin Infect Dis 42:657–668 [View Article][PubMed]
WalshT. R., TolemanM. A., PoirelL., NordmannP.2005; Metallo-β-lactamases: the quiet before the storm?. Clin Microbiol Rev 18:306–325 [View Article][PubMed]
WolterD. J., KhalafN., RobledoI. E., VázquezG. J., SantéM. I., AquinoE. E., GoeringR. V., HansonN. D.2009; Surveillance of carbapenem-resistant Pseudomonas aeruginosa isolates from Puerto Rican Medical Center Hospitals: dissemination of KPC and IMP-18 beta-lactamases. Antimicrob Agents Chemother 53:1660–1664 [View Article][PubMed]